Search

Your search keyword '"Toriola, Adetunji T."' showing total 506 results

Search Constraints

Start Over You searched for: Author "Toriola, Adetunji T." Remove constraint Author: "Toriola, Adetunji T." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
506 results on '"Toriola, Adetunji T."'

Search Results

5. Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic

6. Age-related differences in employment, insurance, and financial hardship among colorectal cancer patients: a report from the ColoCare Study

7. Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study

8. PFAS Levels, Early Life Factors, and Mammographic Breast Density in Premenopausal Women

9. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

12. Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes

13. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset

14. Factors associated with changes in exercise behaviors during the COVID-19 pandemic

16. Association of circulating leukocyte telomere length with survival in patients with colorectal cancer

18. Associations Between Dietary Patterns and Quality of Life in a Longitudinal Cohort of Colorectal Cancer Survivors.

19. Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study.

21. Metabolic disorders in patients diagnosed with colorectal cancer.

23. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study

25. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

26. Psychometric Evaluation of the Powe Fatalism Inventory.

27. Associations between Plasma Choline Metabolites and Genetic Polymorphisms in One-Carbon Metabolism in Postmenopausal Women: The Women's Health Initiative Observational Study

28. Comparison of the disease presentation of early- vs. later-onset colorectal cancer within the prospective ColoCare study.

31. Folate‐mediated one‐carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study

32. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors

33. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women

36. Biomarkers of One-Carbon Metabolism Are Associated with Biomarkers of Inflammation in Women 1–3

37. Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study

39. Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.

42. Trajectories and risk factors of fatigue following colorectal cancer diagnosis

43. Supplemental Table 4 from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

44. Supplemental Table 6 from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

45. Supplemental Table 7 from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

46. Supplemental Figure 3 from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

47. Supplemental Table 2 from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

48. Supplemental Figure 2 from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

49. Supplemental Table 1 from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

50. Data from Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas

Catalog

Books, media, physical & digital resources